Cancer is a community health hazard which progress at a fatal rate in various countries
across the globe. An agent used for chemotherapy should exhibit ideal properties to be an …

Solid lipid nanoparticles (SLN) are considered at the forefront of nanotechnology's rapidly
developing field, with several potential applications in drug delivery and research. SLN …

Pancreatic ductal adenocarcinoma (PDAC) has a devastating prognosis without effective
treatment options. Thus, there is an urgent need for more effective and safe therapies. Here …

The study aim was to develop an intravesical delivery system of quercetin for bladder cancer
management in order to improve drug efficacy, attain a controlled release profile and extend …

The commonly used treatment methods for bone cancer include chemotherapy, surgery and
radiotherapy, but there are disadvantages such as nonspecific distribution, high toxicity of …

Osteosarcoma is the most common primary sarcoma of bone. The use of
Chitooligosaccharide (COS) as a drug carrier is an emerging new strategy for cancer …

Pancreatic cancer represents one of the most lethal cancer types worldwide, with a 5-year
survival rate of less than 5%. Due to the inability to diagnose it promptly and the lack of …

Diseases of the pancreas include acute and chronic pancreatitis, exocrine pancreatic
insufficiency, diabetes and pancreatic cancer. These pathologies can be difficult to treat due …

Gemcitabine (GEM) is a chemotherapeutic drug widely used for treating pancreatic cancer
and other cancers. Despite its efficacy, GEM is associated with adverse side effects and …

Pancreatic ductal adenocarcinoma (PDAC) is a challenge for global health with very low
survival rate and high therapeutic resistance. Hence, advanced preclinical models for …